| VT20455 |
88-15-3 |
2-Acetylthiophene |
C6H6Os |
| VT20456 |
104366-23-6 |
2-AMINO-3-CYANO-4-CHLORO-5-FORMYLTHIOPHENE |
C6H3N2Oscl |
| VT20457 |
40032-76-6 |
2-Bromo-3-bromomethylthiophene |
C5H4Sbr2 |
| VT20458 |
31161-46-3 |
Methanone,(5-bromo-2-thienyl)phenyl- |
C11H7Osbr |
| VT20459 |
96-43-5 |
2-Chlorothiophene |
C4H3ClS |
| VT20452 |
4160-63-8 |
2-(4-Methoxybenzoyl)thiophene |
C12H10O2S |
| VT20461 |
40032-81-3 |
2-Chloro-3-bromomethylthiophene |
C5H4SclBr |
| VT20462 |
16494-36-3 |
2-Iodo-5-methylthiophene |
C5H5Si |
| VT20460 |
57846-02-3 |
2-Chloro-3-(dibromomethyl)thiophene |
C5H3SclBr2 |
| VT20463 |
2689-70-5 |
Methyl tetrahydro-4-methyl-3-oxothiophene-2-carbonate |
C7H10O3S |
| VT20464 |
175201-76-0 |
2-Thiophenecarboxylicacid, 3-chloro-4-(methylsulfonyl)-, methyl ester |
C7H7O4S2Cl |
| VP50373 |
22536-63-6 |
2-Chloro-4-methoxypyrimidine |
C5H5N2OCl |
| VA11987 |
928326-83-4 |
BIBF-1120 |
C31H33N5O4 |
| VA11989 |
467459-31-0 |
1H-Indole-3-ethanamine, 6-fluoro-N-[[3-(2,2,3,3-tetrafluoropropoxy)phenyl]methyl]- |
C20H19N2OF5 |
| VA11990 |
508233-74-7 |
Mirtazapine Related Compound D |
C17H17N3O |
| VA11991 |
845614-11-1 |
Methanone, [4-[3-fluoro-5-(trifluoromethyl)-2-pyridinyl]-1-piperazinyl][5-(methylsulfonyl)- |
C21H20N3O4F7S |
| VA11992 |
1194508-25-2 |
Edivoxetine |
|
| VA11993 |
839712-12-8 |
Urea,
N'-[trans-4-[2-[4-(2,3-dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-N,N
-dimethyl- |
C21H32Cl2N4O |
| VA11994 |
603139-19-1 |
Odanacatib |
C25H27F4N3O3S |
| VA11995 |
929916-05-2 |
DG 051 (free base) |
|
| VA11996 |
393105-53-8 |
1H-Indole-3-aceticacid, a-oxo-1-(phenylmethyl)-5-[4-(trifluoromethoxy)phenyl]- |
C24H16NO4F3 |
| VA11997 |
1050477-31-0 |
Finerenone |
C21H22N4O3 |
| VA11998 |
330942-05-7 |
Betrixaban |
C23H22N5O3Cl |
| VA11999 |
705260-08-8 |
SCH 530348 (H2SO4 Salt) |
C29H33N2O4F.H2O4S |
| VA12000 |
875446-37-0 |
Anacetrapib |
C30H25F10NO3 |
| VA11988 |
262368-30-9 |
N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide |
C14H22N4O |
| VA12001 |
842133-18-0 |
(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol |
C24H25FO5S |
| VA12002 |
850140-72-6 |
Afatinib |
485.94 |
| VA12003 |
870281-82-6 |
Idelalisib |
C22H18N7OF |
| VA12004 |
1061353-68-1 |
PND-1186 |
|
| VA12006 |
755038-65-4 |
BI 6727; Volasertib |
C34H50N8O3 |
| VA12005 |
1032754-93-0 |
GDC0980 |
C23H30N8O3S |
| VA12007 |
915769-50-5 |
Dovitinib |
C21H21N6OF.C3H6O3.H2O |
| VA12009 |
915087-33-1 |
MDV-3100 |
|
| VA12010 |
936091-26-8 |
N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide |
C27H36N6O3S |
| VA12011 |
1056634-68-4 |
CYT 387 |
C23H22N6O2 |
| VA12012 |
941678-49-5 |
Ruxolitinib |
|
| VA12013 |
19171-19-8 |
Pomalidomide |
C13H11N3O4 |
| VA12014 |
918504-65-1 |
PLX4032 |
|
| VA12015 |
1028486-01-2 |
4-[[9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxybenzoic acid |
C27H20ClFN4O4 |
![5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate](http://www.vsnchem.com/usr/uploads/0/201410/VA12051t.jpg)
![2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate](http://www.vsnchem.com/usr/uploads/0/201410/VA12050t.jpg)
![2-Isopropyl-4-[(N-methylamino)methyl]thiazole hydrochloride](http://www.vsnchem.com/usr/uploads/0/201410/VA12049t.jpg)
